D.E. Shaw & Co
RKDA icon

D.E. Shaw & Co’s Arcadia Biosciences RKDA Stock Holding History

D.E. Shaw & Co’s Portfolio RKDA Stock Details RKDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-541
Closed -$22K – 5871
2021
Q4 		$22K Buy
+541
New +$35.3K ﹤0.01% 5287
2020
Q1 		– Sell
-337
Closed -$74K – 4198
2019
Q4 		$74K Sell
337
-4,627
-93% -$928K ﹤0.01% 3889
2019
Q3 		$928K Buy
+4,964
New +$952K ﹤0.01% 2871
2019
Q2 		– Sell
-266
Closed -$74K – 3829
2019
Q1 		$74K Buy
+266
New +$55.6K ﹤0.01% 3497

Other funds holding RKDA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

D.E. Shaw & Co's RKDA Position: Q1 2022 in Review

D.E. Shaw & Co sold out of Arcadia Biosciences (RKDA) in Q1 2022, closing a stake of 541 shares — an estimated $22K sold.

D.E. Shaw & Co first reported a position in RKDA in Q1 2019 and held it in 4 quarters. The position peaked at $928K in Q3 2019. 25 funds tracked by Wall St. Rank hold RKDA as of Q1 2022.

  • D.E. Shaw & Co reported no remaining Arcadia Biosciences position as of Q1 2022 after selling out during the quarter.
  • D.E. Shaw & Co sold 541 Arcadia Biosciences shares in Q1 2022, an estimated $22K.
  • D.E. Shaw & Co first reported a position in Arcadia Biosciences in Q1 2019 and held it in 4 quarters.
  • D.E. Shaw & Co's Arcadia Biosciences position peaked at $928K in Q3 2019.
  • 25 funds tracked by Wall St. Rank held Arcadia Biosciences as of Q1 2022.

Based on D.E. Shaw & Co's 13F filing for Q1 2022, filed 16 May 2022.